Model
Edge
Regeneron Pharmaceuticals, Inc.
0001681643
Filing Type
4
Filing Date
1/4/2022
Updated
1/5/22, 9:24 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership